Lauri I Lavikainen,Gordon H Guyatt,Yung Lee,Rachel J Couban,Anna L Luomaranta,Ville J Sallinen,Ilkka E J Kalliala,Paul J Karanicolas,Rufus Cartwright,Riikka L Aaltonen,Kaisa Ahopelto,Karoliina M Aro,Ines Beilmann-Lehtonen,Marco H Blanker,Jovita L Cárdenas,Samantha Craigie,Päivi J Galambosi,Herney A Garcia-Perdomo,Fang Zhou Ge,Huda A Gomaa,Linglong Huang,Matthew L Izett-Kay,Kirsi M Joronen,Päivi K Karjalainen,Nadina Khamani,Tuomas P Kilpeläinen,Antti J Kivelä,Tapio Korhonen,Hanna Lampela,Anne K Mattila,Borna Tadayon Najafabadi,Taina P Nykänen,Carolina Nystén,Sanna M Oksjoki,Sanjay Pandanaboyana,Negar Pourjamal,Chathura B B Ratnayake,Aleksi R Raudasoja,Tino Singh,Riikka M Tähtinen,Robin W M Vernooij,Yuting Wang,Yingqi Xiao,Liang Yao,Jari Haukka,Kari A O Tikkinen

Abstract:Background: Venous thromboembolism (VTE) and bleeding are serious and potentially fatal complications of surgical procedures. Pharmacological thromboprophylaxis decreases the risk of VTE but increases the risk of major post-operative bleeding. The decision to use pharmacologic prophylaxis therefore represents a trade-off that critically depends on the incidence of VTE and bleeding in the absence of prophylaxis. These baseline risks vary widely between procedures, but their magnitude is uncertain. Systematic reviews addressing baseline risks are scarce, needed, and require innovations in methodology. Indeed, systematic summaries of these baseline risk estimates exist neither in general nor gynecologic surgery. We will fill this knowledge gap by performing a series of systematic reviews and meta-analyses of the procedure-specific and patient risk factor stratified risk estimates in general and gynecologic surgeries. Methods: We will perform comprehensive literature searches for observational studies in general and gynecologic surgery reporting symptomatic VTE or bleeding estimates. Pairs of methodologically trained reviewers will independently assess the studies for eligibility, evaluate the risk of bias by using an instrument developed for this review, and extract data. We will perform meta-analyses and modeling studies to adjust the reported risk estimates for the use of thromboprophylaxis and length of follow up. We will derive the estimates of risk from the median estimates of studies rated at the lowest risk of bias. The primary outcomes are the risk estimates of symptomatic VTE and major bleeding at 4 weeks post-operatively for each procedure stratified by patient risk factors. We will apply the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to rate evidence certainty. Discussion: This series of systematic reviews, modeling studies, and meta-analyses will inform clinicians and patients regarding the trade-off between VTE prevention and bleeding in general and gynecologic surgeries. Our work advances the standards in systematic reviews of surgical complications, including assessment of risk of bias, criteria for arriving at the best estimates of risk (including modeling of the timing of events and dealing with suboptimal data reporting), dealing with subgroups at higher and lower risk of bias, and use of the GRADE approach. Systematic review registration: PROSPERO CRD42021234119.

Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study

Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism

Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease

Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding after TAVR

Predicting intracranial bleeding during anticoagulation for venous thromboembolism within different time frames: Findings from the RIETE registry

Impact of the VTE-PREDICT calculator on clinicians' decision making in fictional patients with venous thromboembolism: a randomized controlled trial

Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial

Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery

Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis

Venous thromboembolism risk following temporary immobilisation after injury: evaluation of the Aberdeen VTE risk tool

Effect of Bleeding Risk Prediction on Decision Making of Intravenous Thrombolysis Before Thrombectomy: a Subgroup Analysis of DIRECT-MT.

[Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores]

Validation of the RIETE, Kuijer, and HAS-BLED Models to Assess 3-Month Bleeding Risk in Anticoagulated Patients Diagnosed with Venous Thromboembolic Disease

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes

Calculation of HAS-BLED Score Is Useful for Early Identification of Venous Thromboembolism Patients at High Risk for Major Bleeding Events: A Prospective Outpatients Cohort Study

Prophylactic transcatheter arterial embolization reduces rebleeding in non-variceal upper gastrointestinal bleeding: A meta-analysis

INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events after Gastrointestinal Bleeding.

Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology

Accuracy Of Has-Bled And Other Bleeding Risk Assessment Tools In Predicting Major Bleeding Events In Atrial Fibrillation: A Network Meta-Analysis

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR